From: Molecular detection of urogenital mollicutes in patients with invasive malignant prostate tumor
| PCa (n = 50) | BPH (n = 55) | |||
|---|---|---|---|---|
| Age (years) | ||||
| < 60 | 2 | (4%) | 5 | (9%) |
| 60–69 | 9 | (18%) | 17 | (31%) |
| 70–79 | 23 | (46%) | 22 | (40%) |
| > 79 | 16 | (32%) | 11 | (20%) |
| PSA level (ng/ml) | ||||
| 0–4 | 4 | (8%) | 17 | (31%) |
| 4.1–10 | 7 | (14%) | 17 | (31%) |
| 10.1–20 | 8 | (16%) | 14 | (25%) |
| > 20 | 31 | (62%) | 7 | (13%) |
| Gleason score | ||||
| 6–7 | 12 | (24%) | – | – |
| 8–10 | 38 | (76%) | – | – |